Please login to the form below

Not currently logged in
Email:
Password:

Ranbaxy launches generic version of AZ drug

Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US
Ranbaxy Pharmaceuticals in agreement with AstraZeneca (AZ) has launched a generic version of Prilosec in the US.

Prilosec, a treatment for conditions caused by excess stomach acid, was originally developed and marketed by AZ and experienced sales in the US of $204.2m, according to IMS data cited by Ranbaxy. Under the terms of the new agreement Ranbaxy Pharmaceuticals - a wholly owned subsidiary of India's largest pharma company, Ranbaxy Laboratories - will begin manufacturing the drug using its generic name, omeprazole.

"We welcome the opportunity to market an authorised generic of omeprazole 40mg capsules that will be commercialised immediately to all classes of trade in the US healthcare system under the Ranbaxy label," said Jim Meehan, vice-president of sales and distribution for RPI.

RPI is based in Florida and markets products to the US healthcare system.

28th July 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....

Infographics